Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > May 2017

« Previous month Next month »

J&J confident of retaining Remicade rewards as biosimilar clouds gather

31-May-2017 - Bestselling biologic Remicade (infliximab) will remain a multi-billion dollar product for J&J for at least the next five years, even with biosimilar competition the firm says.

Merck KGaA taps Selexis cell line tech for immuno-oncology antibodies

31-May-2017 - A Merck KGaA has signed a licensing agreement for Selexis’ SUREtechnology platform and its suspension-adapted CHO-K1 cell line.

Merck & Co. €280m spend in latest commitment to Irish biomanufacturing

31-May-2017 - Global demand for its biologics and vaccines has driven expansion plans and 300 jobs across two Irish facilities says MSD.

40 in, 200 out: Novartis hires and fires in New Jersey

30-May-2017 - Swiss-headquartered Novartis Pharmaceuticals plans to add 40 positions to its manufacturing facility in Morris Plains, New Jersey, to focus on cell therapies.

Lithuania's Biotechpharma jumps on the 2,000L single-use seed train

30-May-2017 -  Lithuanian CDMO Biotechpharma has completed a €15m ($16.7m) expansion adding more than 2,500L of single-use bioreactor capacity.

Second time the charm for Pfizer’s Epogen biosimilar in US

30-May-2017 - An advisory committee has recommended approval of Retacrit in the US after Pfizer addressed manufacturing and clinical concerns from its first submission in 2015.

LSNE tapped for drug substance manufacturing, fill/finish services

25-May-2017 - LSNE Contract Manufacturing has signed a manufacturing supply agreement with Selecta Biosciences, Inc. through which the CDMO will advance Selecta’s lead candidate, SEL-212.

PPD expands Virginia vaccine lab with an eye on assays

24-May-2017 - Pharmaceutical Product Development LLC (PPD) has expanded its vaccine research services lab in Richmond, Virginia.

Merck rolls out cost cutting high density perfusion media

24-May-2017 - Merck has launched a culture media designed to make perfusion based drug production cheaper.

JSR Corporation invests $30m in CDMO facilities

24-May-2017 - JSR Corporation subsidiary KBI Biopharma is expanding its facilities in Durham, North Carolina and Boulder, Colorado, US, to respond to client needs.

GE looks to single-use modular BioParks to relieve capacity investment risk

23-May-2017 - Incorporating single-use and modular facilities into a vendor run bio-campus could reduce CAPEX spend dilemmas faced by drugmakers says GE Healthcare.

Amgen: Bioprocess intensification and integration key for next-generation manufacturing

23-May-2017 - Its new Singapore single-use plant is a fraction of the size of a conventional commercial facility but next-generation biomanufacturing at Amgen points to even smaller, more integrated sites.

Aduro and Merck & Co to test Keytruda and CRS-207 in second cancer study

22-May-2017 - Merck & Co and Aduro Biotech have announced plans to test Keytruda combined with CRS-207 in patients suffering malignant pleural mesothelioma as a result of exposure to asbestos.

Dr Reddy’s turns to single-use for biosimilar production in India

19-May-2017 - Dr Reddy’s will expand its biosimilar manufacturing capacity in Hyderabad by 4,000L using GE Healthcare’s FlexFactory platform based on single-use technologies.

The automation generation: Sartorius integrates analytics tech

19-May-2017 - Sartorius Stedim Biotech (SSB) has announced it will combine technologies with US-based cell culture analysers Nova Biomedical, as a result of increased customer demand.

Therachon hires Catalent to make protein dwarfism drug for Ph I trial

19-May-2017 - Therachon AG has contracted Catalent Biologics to manufacture a candidate protein therapeutic for a rare form of dwarfism.

Novartis in Switzerland: Biologics job boost but 500 'traditional' jobs to go

19-May-2017 - Novartis will add around 350 Swiss jobs to support its innovative biologics pipeline as it looks to cut 500 more “traditional” development and manufacturing roles.

A happy medium for stem cells? Irvine Scientific launches GMP xeno-free offering

17-May-2017 - Xeno-free and cGMP-manufactured media are highly desired by cell therapy developers, says Irvine Scientific as it launches a medium for hematopoietic stem and progenitor cells (HSPCs).

‘Dual-warhead’ a key differentiator for ADCs, says Synaffix

17-May-2017 - Antibody-drug conjugate (ADC) technology developer Synaffix has been granted a US patent for its dual-warhead HydraSpace platform.

Thermo Fisher: $7.2bn Patheon sits in sweet spot for bioproduction business

17-May-2017 - Thermo Fisher says Patheon will become the most competitive biologics CDMO in the market through direct access to its bioprocessing technologies and capabalities.

Single-use making its mark in India as Stelis teams with MilliporeSigma

16-May-2017 - Stelis Biopharma has partnered with Germany’s Merck on a bioprocessing services centre in Bangalore and says single-use systems could kickstart India’s biomanufacturing sector.

Boehringer Ingelheim opens Shanghai contract biomanufacturing plant

16-May-2017 - Boehringer Ingelheim says the biologics plant it opened in Shanghai, China today will cater for customers targeting local and international markets.

Consolidated vaccine sector urgently needs a workforce booster shot, Sanofi

16-May-2017 - Long life-cycles and significant consolidation in the manufacturing space have led to a lack of skilled workers in the vaccine space, says Sanofi Pasteur.

Norgine increases portfolio in Merus acquisition

16-May-2017 - European Norgine B.V. has agreed to acquire all issued and outstanding shares of Merus Labs International in cash for $342m (€309.6).


How Thermo Fisher buying Patheon could simplify pharma supply chains

15-May-2017 - Thermo Fisher Scientific is set to buy contract manufacturer Patheon, but what would this mean for the life science tech firm?

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...